While national clinical trial participant demographics indicate that progress remains to be made in achieving more accurate representation and equitable access, the status of demographic representation across clinical trials at more granular levels has yet to be compiled. Working with partners in academia and industry, we will develop as accurate a picture as possible of demographic representation in clinical trials conducted within the State of New Jersey. Informed by what we learn through this effort, stakeholders will have a better idea as to where opportunities to achieve more accurate demographic representation lie — both regionally and across therapeutic areas — to facilitate more effective and efficient efforts to achieve greater equity in clinical trials.